Z-2323-2021 Class II Terminated
FDA device recall Z-2323-2021 was initiated by Cytocell Ltd. on May 27, 2021 and is designated Class II. Reason for recall: May show unexpected locus specific signals in addition to those at 19p13.3. Users may observe faint additional locus specific signals at 9q34 The recall status is terminated (terminated May 9, 2022). Affected quantity: 23 units.
Recall Details
- Product Type
- Devices
- Report Date
- August 25, 2021
- Initiation Date
- May 27, 2021
- Termination Date
- May 9, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23 units
Product Description
Cytocell LPH019-A E2A (TCF3) Breakapart Probe- In Vitro Diagnostic Analyte specific reagents (ASR's)
Reason for Recall
May show unexpected locus specific signals in addition to those at 19p13.3. Users may observe faint additional locus specific signals at 9q34
Distribution Pattern
US Nationwide distribution in the states of CA, IL, KY, NY, OH, TX, UT, VA.
Code Information
Lots 073004 and 072518 (Probe lot 200918-006).